Several biomakers has been reported to be as diagnostic and prognostic biomarkers of fibrosing ILD, including Krebs von den lugen-6 (KL-6), Surfactant proteins A and D (SP-A and SP-D), serum interleukin 6 (IL-6) levels and tumor markers8–10. The gene discussed is IL6; the disease is neoplasm.